SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-111940
Filing Date
2016-07-07
Accepted
2016-07-07 15:46:32
Documents
5
Period of Report
2016-08-16
Effectiveness Date
2016-07-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A v443869_def14a.htm DEF 14A 787863
2 GRAPHIC tlogo.jpg GRAPHIC 12826
3 GRAPHIC tproxy1a.jpg GRAPHIC 268272
4 GRAPHIC tproxy1b.jpg GRAPHIC 66284
5 GRAPHIC tproxy2.jpg GRAPHIC 226988
  Complete submission text file 0001144204-16-111940.txt   1580753
Mailing Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120
Business Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120 212-946-4826
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 161756578
SIC: 2836 Biological Products, (No Diagnostic Substances)